A New Approach to Biochemical Evaluation of Brain Dopamine Metabolism

Overview

Journal Cell Mol Neurobiol

Publisher Springer

Specialties Cell Biology
Molecular Biology
Neurology

Date 1988 Jun 1

PMID 3044592

Citations 8

Authors

I J Kopin

J H White

K Bankiewicz

Affiliations

Soon will be listed here.

Abstract

1. Dopaminergic neurotransmission in brain is receiving increased attention because of its known involvement in Parkinson's disease and new methods for the treatment of this disorder and because of hypotheses relating several psychiatric disorders to abnormalities in brain dopaminergic systems. 2. Chemical assessment of brain dopamine metabolism has been attempted by measuring levels of its major metabolite, homovanillic acid (HVA), in cerebrospinal fluid, plasma, or urine. Because HVA is derived in part from dopamine formed in noradrenergic neurons, plasma levels and urinary excretion rates of HVA do not adequately reflect solely metabolism of brain dopamine. 3. Using debrisoquin, the peripheral contributions of HVA to plasma or urinary HVA can be diminished, but the extent of residual HVA formation in noradrenergic neurons is unknown. By measuring the levels of methoxy-hydroxyphenylglycol (MHPG) in plasma or of urinary norepinephrine metabolites (total MHPG in monkeys; the sum of total MHPG and vanillyl mandelic acid (VMA) in humans) along with HVA, it is possible to estimate the degree of impairment by debrisoquin of HVA formation from noradrenergic neuronal dopamine and thereby better assess brain dopamine metabolism. 4. This method was applied to a monkey before and after destruction of the nigrostriatal pathway by the administration of MPTP.

Citing Articles

Decreased urinary excretion of norepinephrine and dopamine in autonomic synucleinopathies.

Goldstein D, Sullivan P, Holmes C Clin Auton Res. 2024; .

PMID: 39656385 DOI: 10.1007/s10286-024-01093-6.

Dopaminergic metabolism is affected by intracerebral injection of Tb II-I isolated from scorpion venom.

Emidio B, Ivo L, Leonor Abrahao N Toxicon X. 2022; 15:100126.

PMID: 35663624 PMC: 9160406. DOI: 10.1016/j.toxcx.2022.100126.

Reward Dependence-Moderated Noradrenergic and Hormonal Responses During Noncompetitive and Competitive Physical Activities.

Nagy Z, Karsai I, Nagy T, Katai E, Miseta A, Fazekas G Front Behav Neurosci. 2022; 16:763220.

PMID: 35558438 PMC: 9087724. DOI: 10.3389/fnbeh.2022.763220.

Placental Barrier and Autism Spectrum Disorders: The Roles of Prolactin and Dopamine in the Developing Fetal Brain-Part II.

Yarlagadda A, Acharya G, Kasaraneni J, Hampe C, Clayton A Innov Clin Neurosci. 2020; 16(11-12):36-39.

PMID: 32082942 PMC: 7006862.

Tyrosinemia type I and not treatment with NTBC causes slower learning and altered behavior in mice.

Hillgartner M, Coker S, Koenig A, Moore M, Barnby E, MacGregor G J Inherit Metab Dis. 2016; 39(5):673-682.

PMID: 27271696 DOI: 10.1007/s10545-016-9949-6.

References

Suzuki H, Nakane H, Kawamura M, Yoshizawa M, Takeshita E, Saruta T . Excretion and metabolism of dopa and dopamine by isolated perfused rat kidney. Am J Physiol. 1984; 247(3 Pt 1):E285-90. DOI: 10.1152/ajpendo.1984.247.3.E285. View

Brown M, Dollery C . A specific radioenzymatic assay for dihydroxyphenylalanine (DOPA). Plasma dopa may be the precursor of urine free dopamine. Br J Clin Pharmacol. 1981; 11(1):79-83. PMC: 1401704. DOI: 10.1111/j.1365-2125.1981.tb01106.x. View

Burns R, Lewitt P, EBERT M, Pakkenberg H, Kopin I . The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). N Engl J Med. 1985; 312(22):1418-21. DOI: 10.1056/NEJM198505303122203. View

Carlsson A . The occurrence, distribution and physiological role of catecholamines in the nervous system. Pharmacol Rev. 1959; 11(2, Part 2):490-3. View

Scatton B, Dennis T, Curet O . Increase in dopamine and DOPAC levels in noradrenergic terminals after electrical stimulation of the ascending noradrenergic pathways. Brain Res. 1984; 298(1):193-6. DOI: 10.1016/0006-8993(84)91169-7. View

Scheinin H . Enhanced noradrenergic neuronal activity increases homovanillic acid levels in cerebrospinal fluid. J Neurochem. 1986; 47(3):665-7. DOI: 10.1111/j.1471-4159.1986.tb00662.x. View

Hornykiewicz O . Dopamine (3-hydroxytyramine) and brain function. Pharmacol Rev. 1966; 18(2):925-64. View

ANDEN N, Grabowska-Anden M, Lindgren S, Oweling M . Very rapid turnover of dopamine in noradrenaline cell body regions. Naunyn Schmiedebergs Arch Pharmacol. 1985; 329(3):258-63. DOI: 10.1007/BF00501877. View

Portig P, Vogt M . Release to the cerebral ventricles of substances with possible transmitter function in the caudate nucleus. J Physiol. 1969; 204(3):687-715. PMC: 1351581. DOI: 10.1113/jphysiol.1969.sp008939. View

10.

ANDEN N, Grabowska-Anden M . Formation of deaminated metabolites of dopamine in noradrenaline neurons. Naunyn Schmiedebergs Arch Pharmacol. 1983; 324(1):1-6. DOI: 10.1007/BF00647830. View

11.

Chase T, Eng N, Gordon E . Biochemical aids in the diagnosis of Parkinson's disease. Ann Clin Lab Sci. 1976; 6(1):4-10. View

12.

Bareggi S, Marc V, Morselli P . Urinary excretion of 3-methoxy-4-hydroxyphenylglycol sulfate in rats after intraventricular injection of 6-OHDA. Brain Res. 1974; 75(1):177-80. DOI: 10.1016/0006-8993(74)90781-1. View

13.

Kopin I, Bankiewicz K, Harvey-White J . Effect of MPTP-induced parkinsonism in monkeys on the urinary excretion of HVA and MHPG during debrisoquin administration. Life Sci. 1988; 43(2):133-41. DOI: 10.1016/0024-3205(88)90290-1. View

14.

Kopin I . Catecholamine metabolism: basic aspects and clinical significance. Pharmacol Rev. 1985; 37(4):333-64. View

15.

Kendler K, Heninger G, Roth R . Brain contribution to the haloperidol-induced increase in plasma homovanillic acid. Eur J Pharmacol. 1981; 71(2-3):321-6. DOI: 10.1016/0014-2999(81)90034-0. View

16.

Post R, Goodwin F, Gordon E, WATKIN D . Amine metabolites in human cerebrospinal fluid: effects of cord transection and spinal fluid block. Science. 1973; 179(4076):897-9. DOI: 10.1126/science.179.4076.897. View

17.

BARTHOLINI G, Tissot R, Pletscher A . Brain capillaries as a source of homovanillic acid in cerebrospinal fluid. Brain Res. 1971; 27(1):163-8. DOI: 10.1016/0006-8993(71)90378-7. View

18.

Shum A, Van Loon G, Sole M . Measurement of L-dihydroxyphenylalanine in plasma and other biological fluids by high pressure liquid chromatography with electrochemical detection. Life Sci. 1982; 31(15):1541-5. DOI: 10.1016/0024-3205(82)90044-3. View

19.

PETTINGER W, Korn A, Spiegel H, Solomon H, POCELINKO R, ABRAMS W . Debrisoquin, a selective inhibitor of intraneuronal monoamine oxidase in man. Clin Pharmacol Ther. 1969; 10(5):667-74. DOI: 10.1002/cpt1969105667. View

20.

Curet O, Dennis T, Scatton B . The formation of deaminated metabolites of dopamine in the locus coeruleus depends upon noradrenergic neuronal activity. Brain Res. 1985; 335(2):297-301. DOI: 10.1016/0006-8993(85)90480-9. View